The future of blood‐based biomarkers for Alzheimer's disease-Reference-Cited by-同舟云学术

The future of blood‐based biomarkers for Alzheimer's disease

Published:2013-07-15 Issue:1 Volume:10 Page:115-131
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Henriksen Kim¹,O'Bryant Sid E.²,Hampel Harald³,Trojanowski John Q.⁴,Montine Thomas J.⁵,Jeromin Andreas⁶,Blennow Kaj⁷,Lönneborg Anders⁸,Wyss‐Coray Tony⁹,Soares Holly¹⁰,Bazenet Chantal¹¹,Sjögren Magnus⁸,Hu William¹²,Lovestone Simon¹¹,Karsdal Morten A.¹,Weiner Michael W.¹³,

Affiliation:

1. Nordic Bioscience Biomarkers and ResearchNeurodegenerative DiseasesHerlevDenmark

2. Department of Internal MedicineUniversity of North Texas Health Science CenterFort WorthTexasUSA

3. Department of PsychiatryUniversity of FrankfurtFrankfurtGermany

4. Institute on Aging, Alzheimer's Disease Core Center, Udall Parkinson's Research Center, Center for Neurodegenerative Disease ResearchDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA

5. Department of PathologyUniversity of WashingtonSeattleWAUSA

6. NextGen SciencesAnn ArborMIUSA

7. Clinical Neurochemistry Laboratory, Department of Neuroscience and PhysiologyUniversity of Goteborg, Sahlgrenska University HospitalMolndalSweden

8. DiaGenic ASAOsloNorway

9. Department of Neurology and Neurological SciencesStanford University School of MedicineStanfordCAUSA

10. Bristol‐Myers SquibbWallingfordCTUSA

11. King's College London, Department of Old Age PsychiatryInstitute of PsychiatryDe Crespigny ParkLondonUK

12. Department of Neurology, Center for Neurodegenerative Disease ResearchEmory University School of MedicineAtlantaGAUSA

13. Departments of Medicine, Radiology, Psychiatry, and NeurologyUniversity of CaliforniaSan FranciscoCAUSA

Funder

Vetenskapsrådet

National Institutes of Health

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.01.013

Reference140 articles.

1. Current and Emerging Drug Treatment Options for Alzheimerʼs Disease

2. Blood-based biomarkers of Alzheimer’s disease: challenging but feasible

3. Biomarkers in Alzheimer's disease drug development

4. Biomarkers in Alzheimer's disease drug development

5. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct plasma phosphorylated-tau proteins profiling for the differential diagnosis of mild cognitive impairment and Alzheimer's disease by plasmonic asymmetric nanobridge-based biosensor;Biosensors and Bioelectronics;2024-04

2. Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-01-30

3. Novel Plasma Protein Biomarkers: A Time-Dependent predictive model for Alzheimer's Disease;2023-11-30

4. Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease;Alzheimer's & Dementia;2023-11-06

5. Reverse engineering therapeutic mechanisms of ketamine and Psychedelics: Insights from Translational Oncology for Research in Psychiatry;Personalized Medicine in Psychiatry;2023-11